Alfacalcidol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01436 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 11 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | familial isolated hypoparathyroidism due to impaired PTH secretion | KG + DL |
| 2 | Dahlberg-Borer-Newcomer syndrome | KG + DL |
| 3 | craniofacial conodysplasia | KG + DL |
| 4 | acromesomelic dysplasia, Campailla Martinelli type | KG + DL |
| 5 | renal tubular acidosis | KG + DL |
| 6 | pseudo-von Willebrand disease | KG + DL |
| 7 | primary release disorder of platelets | KG + DL |
| 8 | parathyroid hyperplasia (disease) | KG + DL |
| 9 | familial isolated hypoparathyroidism due to agenesis of parathyroid gland | KG + DL |
| 10 | Glanzmann thrombasthenia | KG + DL |
| 11 | obsolete vitamin D deficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.